Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPA1P44 is a **pseudogene** of the heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from duplication or retrotransposition events. HNRNPA1P44 does not encode a functional protein and thus is not considered a drug target, molecular receptor, or enzyme. The functional gene, HNRNPA1, encodes a key RNA-binding protein involved in a variety of RNA metabolic processes such as alternative splicing, RNA transport, and telomere maintenance; however, pseudogenes like HNRNPA1P44 lack known protein-coding capacity or biological activity in cellular processes[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 44 (HNRNPA1P44).